Rocket Pharmaceuticals (RCKT) Invested Capital (2014 - 2021)

Rocket Pharmaceuticals has reported Invested Capital for 3 years, with the latest figure at $52.0 million in Q3 2017.

• Quarterly Invested Capital changed 0.0% year-over-year to $52.0 million in Q3 2017, while the trailing twelve-month figure through Jun 2018 was $52.0 million (down 75.0% YoY) and the FY2016 annual result came in at $52.0 million, changed N/A from the prior year.
• Invested Capital was little changed at $52.0 million in Q3 2017 per RCKT's latest filing, from $52.0 million in the prior quarter.
• Over five years, Invested Capital peaked at $52.0 million in Q3 2016 and troughed at $21.0 million in Q1 2015.
• A 3-year average of $43.1 million and a median of $52.0 million in 2016 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 0.0% in 2017, down 0.0% in 2017.
• Over 3 years, Invested Capital stood at $21.0 million in 2015, then surged by 147.62% to $52.0 million in 2016, then changed by 0.0% to $52.0 million in 2017.
• According to Business Quant data, Invested Capital over the past three periods registered $52.0 million, $52.0 million, and $52.0 million for Q3 2017, Q2 2017, and Q1 2017 respectively.